Back to Blog
Market Analysis

From Charge Trap to Cure: The AIM2 Therapeutic Pipeline

Mapping the multi-billion dollar market opportunity in SLE, psoriasis, and neurodegenerative disease.

Q-RETIX Research Team

Market Analysis

June 15, 2026
8 min read
From Charge Trap to Cure: The AIM2 Therapeutic Pipeline
Research updates

Follow the work as it develops.

Receive occasional Q-RETIX research articles, transparent product progress, and opportunities to contribute feedback.

Research notes

New articles, methods, and scientific explainers.

Product progress

Transparent updates as research concepts become prototypes.

Early opportunities

Occasional invitations to feedback sessions or beta access.

Join the list

Stay close to the research.

Join the Q-RETIX waitlist with a verified email address. We will only use it for research updates and early-access opportunities.

We collect only the information you provide after email verification. Read the Privacy Policy.

Prefer a direct conversation?

Meet Q-RETIX
No automatic enrollmentNo fabricated success messageResearch communications only